We successfully integrated cancer-associated OptoPLC-γ1 variants63 to create many cell lines in a common PLC-γ1-null background, and we showed that light stimulation of lines expressing gain-of-function mutant OptoPLC-γ1s triggers PIP2 hydrolysis. The gene discussed is PLCG1; the disease is cancer.